Obama’s Call for International Regulatory Harmonization Could Help Drug Industry

The FDA may need to better align its regulations with those of key trading partners, a move that could benefit the increasingly global drug industry, thanks to a new executive order (EO) signed by President Barack Obama Tuesday. The “Promoting International Regulatory Cooperation” order asks federal agencies to reform existing requirements that unnecessarily differ from those of the U.S.’s major trading partners.
Drug Industry Daily